Matthew C. Riddle, MD
Dr. Riddle attended Yale University (BA 1960, magna cum laude) and Harvard Medical School (MD 1964). His internship and residency in internal medicine were at Rush-Presbyterian-St. Luke’s Medical Center in Chicago, and he completed two fellowships in Endocrinology and Metabolism, one at Rush Presbyterian-St. Luke’s with Dr. Theodore Schwartz (1969-71), the other at the University of Washington in Seattle with Dr. Robert Williams (1971-73). Since 1973 he has been at Oregon Health & Science University, where he is Professor of Medicine in the Division of Endocrinology, Diabetes, & Clinical Nutrition. His interests include the physiology of type 2 diabetes, newer therapeutic regimens, cardiovascular outcomes of diabetes, and the organization of care for diabetes. In particular, he is interested in the use of basal insulin therapy, combination therapy with insulin and oral agents, and the use of GLP-1 receptor agonists and amylin agonists for management of postprandial hyperglycemia. He has more than 180 scholarly publications and is currently an Associate Editor of Diabetes Care. He has had leadership responsibilities in various large collaborative trials testing the effects of treatments on outcomes in type 1 and type 2 diabetes, among them DCCT/EDIC, ACCORD/ACCORDION, ORIGIN/ORIGINALE, ELIXA, REWIND, and EXSCEL. He received the American Diabetes Association’s Outstanding Physician-Clinician Award for year 2005.